PACTR202106708800075尚未招募未知
Evaluation of population diversity of Plasmodium falciparum isolates from children with uncomplicated infection during the adoption of artemisinin-based combination therapy in Nigeria
Kazeem Akano0 个研究点目标入组 75 人开始时间: 2021年6月16日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
- 入组人数
- 75
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 1 Month(s) 至 23 Month(s)（—）
- 性别
- All
入选标准
- •History of fever or fever (temp > 37.5oC)
- •Mono P. falciparum infection with asexual parasitemia of =2000 mL-1
- •Written informed consent, including readiness to comply with follow-up visits by the child’s parent or guardian.
排除标准
- •Signs of severe malaria
- •severe malnutrition
- •History of allergy to study drug
研究者
相似试验
尚未招募
不适用
nderstanding Plasmodium falciparum malaria in the Amazon: implications for the national malaria control programncomplicated malariaPlasmodium falciparumBrazilPlasmodium falciparum histidine-rich protein-2 genetherapeutic efficacy trialArtemisinin-based combination therapyParasitological clearance rateRBR-634ymd5Instituto Nacional de Infectologia Evandro Chagas
招募中
不适用
Comparison of three Plasmodium falciparum isolates in an experimental human malaria infectioplasmodium falciparum10037072MalariaNL-OMON34733niversitair Medisch Centrum Sint Radboud15
已完成
不适用
Comparison of three Plasmodium falciparum isolates in a controlled human malaria infectiomalariaNL-OMON37044niversitair Medisch Centrum Sint Radboud15
已完成
不适用
Efficacy of artemether-lumefantrine treatment in uncomplicated malaria (Plasmodium falciparum) patients and in-vitro experiment on susceptibility of malaria (P. falciparum) strains to new chemical substancesISRCTN08391109Medicines for Malaria Venture (MMV) (Switzerland)110
已完成
不适用
Safety, Tolerability and Plasmodium falciparum transmission-reducing activity of R0.6C vaccine adjuvanted with Alhydrogel alone or combined with Matrix-M in healthy malaria-naïve adults in the NetherlandsmalariaNL-OMON51178Radboud Universitair Medisch Centrum32